|
| 34215508 | COVID-19 Seminars Issue 2 - Introduction. | Urol Oncol | 2023 |
| 37805339 | Bladder cancer patient and provider perspectives on smoking cessation. | Urol Oncol | 2023 |
| 37558582 | AUTHOR REPLY. | Urology | 2023 |
| 37509333 | The Judicious Use of Stereotactic Ablative Radiotherapy in the Primary Management of Localized Renal Cell Carcinoma. | Cancers (Basel) | 2023 |
| 38040458 | ACR Appropriateness Criteria® Acute Onset Flank Pain-Suspicion of Stone Disease (Urolithiasis). | J Am Coll Radiol | 2023 |
| 37221660 | Patient-centered outcomes of telehealth for the care of rural-residing patients with urologic cancer. | Cancer | 2023 |
| 37390972 | Attitudes Among Society of Women in Urology Members Toward Dobbs v. Jackson Women's Health Organization. | Urology | 2023 |
| 36950915 | Editorial Comment. | J Urol | 2023 |
| 36990941 | The effect of treatment on work productivity in patients with bladder cancer. | Urol Oncol | 2023 |
| 37150667 | Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy. | Clin Genitourin Cancer | 2023 |
| 37463855 | Putting patients first to redefine prostate cancer classifications. | J Natl Cancer Inst | 2023 |
| 36695825 | Multi-pilot implementation experiences of patient-centered pathology reports: lessons learned for the advancement of patient-centered tools for cancer decision-making. | Cancer Causes Control | 2023 |
| 36920395 | Early Pregnancy Loss Management in the Emergency Department vs Outpatient Setting. | JAMA Netw Open | 2023 |
| 36441070 | A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive nephrectomy. | Urol Oncol | 2023 |
| 36776124 | Racial inequities in the quality of surgical care among Medicare beneficiaries with localized prostate cancer. | Cancer | 2023 |
| 36710146 | A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder Cancer. | Clin Genitourin Cancer | 2023 |
| 36600087 | Prostate cancer risk, screening and management in patients with germline BRCA1/2 mutations. | Nat Rev Urol | 2023 |
| 36529652 | Palliative care knowledge, attitudes, and experiences amongst patients with bladder cancer and their caregivers. | Urol Oncol | 2023 |
| 34247905 | Applicant perceptions of virtual interviews for society of urologic oncology fellowships during the COVID-19 pandemic. | Urol Oncol | 2023 |
| 34162499 | Discomfort and relieving factors among patients with bladder cancer undergoing office-based cystoscopy. | Urol Oncol | 2022 |
| 35445202 | Aggressive Prostate Cancer at Presentation Following Solid Organ Transplantation. | Eur Urol Open Sci | 2022 |
| 35550799 | ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update. | J Am Coll Radiol | 2022 |
| 35793109 | Spending and Out-of-Pocket Costs for Genital Gender-Affirming Surgery in the US. | JAMA Surg | 2022 |
| 35367082 | Deconstructing, Addressing, and Eliminating Racial and Ethnic Inequities in Prostate Cancer Care. | Eur Urol | 2022 |
| 35394343 | A Patient-Centered Approach to Research Prioritization in Prostate Cancer. | J Urol | 2022 |
| 35623004 | Building the Canadian Bladder Cancer Research Network (CBCRN): Progress during a pandemic. | Can Urol Assoc J | 2022 |
| 37145718 | Naloxegol versus Alvimopan for Enhancing Postoperative Recovery following Radical Cystectomy for Bladder Cancer. | Urol Pract | 2022 |
| 36436954 | ACR Appropriateness Criteria® Acute Pyelonephritis: 2022 Update. | J Am Coll Radiol | 2022 |
| 36601043 | Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis. | Eur Urol Open Sci | 2022 |
| 36040190 | Comprehension, utility, and preferences of prostate cancer survivors for visual timelines of patient-reported outcomes co-designed for limited graph literacy: meters and emojis over comics. | J Am Med Inform Assoc | 2022 |
| 36082551 | Editorial Comment. | J Urol | 2022 |
| 36183417 | Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer: Results From an Administrative Dataset. | Alzheimer Dis Assoc Disord | 2022 |
| 34985341 | Reply by Authors. | J Urol | 2022 |
| 35309011 | Design of digital walking programs that engage prostate cancer survivors: Needs and preferences from focus groups. | AMIA Annu Symp Proc | 2022 |
| 34875105 | Using a multilevel implementation strategy to facilitate the screening and treatment of tobacco use in the outpatient urology clinic: A prospective hybrid type I study. | Cancer | 2022 |
| 35304799 | Associations of self-efficacy, social support and coping strategies with health-related quality of life after radical cystectomy for bladder cancer: A cross-sectional study. | Eur J Cancer Care (Engl) | 2022 |
| 34967664 | Translating Patient-Centered Research into Educational Resources to Address Racial Inequities in Prostate Cancer. | J Urol | 2022 |
| 34991070 | Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 35260844 | Implementation of patient-reported outcome measures into health care for men with localized prostate cancer. | Nat Rev Urol | 2022 |
| 34757049 | Strategies to Optimize Nephrolithiasis Emergency Care (STONE): Prospective Evaluation of an Emergency Department Clinical Pathway. | Urology | 2022 |
| 34516660 | Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer. | Cancer | 2022 |
| 32800624 | "Help me figure this out": Qualitative explorations of patient experiences with cancer pathology reports. | Patient Educ Couns | 2021 |
| 35387424 | A Prospective Study of a Resorbable Intravesical Fiducial Marker for Bladder Cancer Radiation Therapy. | Adv Radiat Oncol | 2021 |
| 37145620 | Association of the 2012 American Urological Association Vasectomy Guidelines with National Trends in Vasectomy Followup in the United States. | Urol Pract | 2021 |
| 37145445 | Understanding the Economic Burden of Treating Low-Grade Upper Tract Urothelial Cancer in the United States. | Urol Pract | 2021 |
| 37145425 | Washington State Surgeon Perspectives on Quality Measures in the Surgical Care of Stress Urinary Incontinence in Women. | Urol Pract | 2021 |
| 33549205 | AUTHOR REPLY. | Urology | 2021 |
| 33766465 | Cost-effectiveness analysis of neoadjuvant immune checkpoint inhibition vs. cisplatin-based chemotherapy in muscle invasive bladder cancer. | Urol Oncol | 2021 |
| 33676849 | High-intensity end-of-life care among Medicare beneficiaries with bladder cancer. | Urol Oncol | 2021 |
| 33898656 | Underutilization of Surgical Standard of Care for Insured Men with Invasive Penile Cancer. | Urol Pract | 2021 |